===================== Product Identification =====================
MSDS NAME:FORANE (R) 502, 04007
NIIN:01-357-4840
Status Code:A
MSDS Number: CJDWC
=== Responsible Party ===
Company:ELF ATOCHEM NORTH AMERICA INC
Address:2000 MARKET ST
City:PHILADELPHIA
State:PA
ZIP:19103-3222
Country:US
Info Phone Num:215-419-7695
Emergency Phone Num:215-419-7704
Chemtrec Ind/Phone:(800)424-9300
CAGE:86460
=== Contractor Identification ===
Company:ELF ATOCHEM NORTH AMERICA INC
Address:2000 MARKET STREET
Box:City:PHILADELPHIA
State:PA
ZIP:19103-3222
Country:US
Phone:800-245-5858
CAGE:86460
============= Composition/Information on Ingredients =============
Name:CHLORODIFLUOROMETHANE (R-22)
CAS:75-45-6
RTECS #:PA6390000
= Wt:48.8
OSHA PEL:1000 PPM, 3500 MG/M3
ACGIH TLV:3540 MG/M3;1000 PPM
Ozone Depleting Chemical:2
Name:1-CHLOROPENTAFLUOROETHANE; (CHLOROPENTAFLUOROETHANE
(R-115))
CAS:76-15-3
RTECS #:KH7877500
= Wt:51.2
OSHA PEL:1000 PPM, 6320 MG/M3
ACGIH TLV:6320 MG/M3;1000 PPM
Ozone Depleting Chemical:1
===================== Hazards Identification =====================
LD50 LC50 Mixture:NONE SPECIFIED BY MANUFACTURER.
Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:CHLOROFLUOROCARBON (CFC) MATLS HAVE
PRODUCED SENSITIZATION OF MYOCARDIUM TO EPINEPHRINE IN LAB ANIMALS
& COULD HAVE SIMILAR EFT IN HUMANS. ADRENOMIMETICS (E.G.,
EPINEPHRINE) MAY BE CONTRAINDICATED EXC EPT FOR LIFE-SUSTAINING
USES IN HUMANS ACUTELY/CHRONICALLY EXPOSED TO CFC'S. . FORANE 22:
AS W/MOST LIQUEFIED GASES, CONT W/RAPIDLY VOLATILIZING LIQ/COLD VAP
CAN CAUSE FROSTBITE TO ANY TISS. BA SED ON SINGLE EXPOSURE ANIMAL
TESTS, HCFC 22 IS CONSIDERED TO BE PRACTICALLY NON-TOXIC IF
INHALED. HOWEVER, IF EXPOS TO HCFC 22 GAS @ HIGH CONCS MAY EFT
NERVOUS SYS & PRDCE RAPID ANETSTH EFT. DENSE VA P OF HCFC 22 CAN
REDUCE(EFTS OF OVEREXP)
Explanation of Carcinogenicity:NOT RELEVANT.
Effects of Overexposure:HLTH HAZS: OXYG AVAIL FOR BRTHG & PRDCE SYMPS
SUCH AS HDCH, DIZZ, DROW, CYANOSIS & LACK OF MUSC CONTROL FOLLOWED
BY COLLAPSE. PRLGD EXPOS TO OXYG DEFICIENT ATM MAY BE FATAL. INHAL
OF HCFC 22 MAY CAU SE INCR IN SENSIT OF HEART TO ADRENALINE, WHICH
COULD RSLT IN IRREG HEART BEATS & REDUCED HEART FUNC. FORANE 115:
AS W/MOST LIQUIFIED GASES, CONT W/RAPIDLY VOLATILIZING LIQ/COLD
VAPS CAN CAUSE FROSTBT TO ANY TISS DUE TO CRYOGENIC (EXTREME LOW
TEMP) EFT OF MATL. ACUTE STUDIES W/ANIMALS INDICATE CFC 115 IS
PRACTICALLY NON-TOX BY INHAL RTE. HOWEVER, EXPOS TO CFC 115 GAS AT
HIGH CONCS MAY EFT NERV SYS & PRDCE RAPID ANESTH EFT. (SUPDAT)
Medical Cond Aggravated by Exposure:WORKERS WITH HEART DISEASE OR
COMROMISED HEART FUNCTION SHOULD LIMIT EXPOSURE TO THIS MATERIAL.
======================= First Aid Measures =======================
First Aid:INGESTION: PRODUCT IS GAS AT AMBIENT CONDITIONS. NEVER GIVE
ANYTHING BY MOUTH TO UNCONSCIOUS PERSON. SKIN: FLUSH W/LUKEWARM
WATER (NOT HOT)-OR USE OTHER MEANS TO WARM SKIN SLOWLY. GET MEDICAL
ATTENTIO N IF FROSTBITTEN BY LIQUID/IF IRRITATIONOCCURS. EYE
CONTACT: IMMEDIATELY FLUSH W/PLENTY OF WATER FOR AT LEAST 15
MINUTES. GET MED ATTENTION. INHALATION: REMOVE TO FRESH AIR. IF NOT
BREATHING, GIVE ART IFICIAL RESPIRATION. IF BREATHING IS DIFFICULT,
GIVE OXYGEN. GET MEDICAL ATTENTION.
===================== Fire Fighting Measures =====================
Flash Point:NON FLAMMABLE
Extinguishing Media:USE EXTINGUISHING MEDIA APPROPRIATE TO SURROUNDING
FIRE CONDITIONS.
Fire Fighting Procedures:WEAR NIOSH APPROVED PRESSURE DEMAND SCBA &
FULL PROTECTIVE EQUIPMENT . KEEP CONTAINERS COOL.
Unusual Fire/Explosion Hazard:THERMAL DECOMPOSITION PRODS MAY INCL
CHLORIDES, FLUORIDES & PHOSPHENE . MAY DECOMPOSE DURING CONTACT
W/FLAMES, HEATING ELEMENTS OR IN COMBUSTION ENGINES RELEASING
IRRITATING, TOXIC & CORROSIVE G ASES. CONTAINER MAY EXPLODE IF
HEATED DUE TO RESULTING PRESSURE RISE.
================== Accidental Release Measures ==================
Spill Release Procedures:REMOVE OR EXTINGUISH IGNITION/COMBUSTION
SOURCES. EVACUATE ENCLOSED SPACES UNTIL GAS IS DISPERSED. KEEP
UPWIND. STOP LEAK IF POSSIBLE W/OUT RISK. DISPERSE GAS
W/FLOOR-LEVEL FORCED-AIR VENTILATION. EXH AUST VAPORS OUTDOORS.
REMOVE ALL FLAMES,HEATING ELEMENTS & GAS ENGINES. WASH CONTAMINATED
CLOTHES BEFORE USE. DESTROY CONTAMINATED SHOES.
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.
====================== Handling and Storage ======================
Handling and Storage Precautions:NO SMOKING IN AREA OF USE. DO NOT USE
IN GENERAL VICINITY OF ARC WELDING, OPEN FLAMES/HOT SURFACES. HEAT
&/OR UV RADIA MAY CAUSE FORMATION OF CHLORIDES, FLUORIDES &
PHOSGENE . DO NOT GET IN EYES , ON SKIN/CLTHG. DO NOT BRTHE VAP,
MIST/GAS. KEEP CNTNR CLSD. KEEP AWAY FROM HEAT, SPARKS & FLAMES.
Other Precautions:STORE IN TIGHTLY CLOSED CONTAINERS. EMPTY CONTAINER
MAY CONTAIN HAZARDOUS RESIDUE. DO NOT DROP, REUSE/REFILL CONTAINER.
DO NOT SMOKE. READ LABEL BEFORE USE. DO NOT CUT, GRIND OR WELD ON
OR NEAR CONTAI NER DUE TO POSSIBLE TOXIC FUME GENERATION.
============= Exposure Controls/Personal Protection =============
Respiratory Protection:AVOID BRTHG VAP, MIST/FUME. USE NIOSH APPRVD
FULL FACE (TC-19C) SUPPLIED AIR RESP/SCBA WHERE AIRBORNE EXPOSURE
IS LIKELY TO EXCEED REC EXPOSURE LIMITS. IF USED, NIOSH APPRVD FULL
FACEPIECE REPLACES NE ED FOR ANSI APPRVD CHEM GOGGS AND/OR
FACESHIELD. IF EXPOS CANNOT BE KEPT AT MIN W/ENGINEERING CTLS, USE
NIOSH APPRVD RESP EQUIP AS NOTED ABOVE. (OTHER INFO)
Ventilation:INVESTIGATE ENGINEERING TECHNIQUES TO REDUCE EXPOS <
AIRBORNE EXPOS LIMS. PROVIDE VENT IF NEC TO CTL EXPOS LEVELS BELOW
AIRBORNE EXPOS LIMS (SEE (OTHER INFO)
Protective Gloves:SYNTHETIC RUBB GLOVES SUCH AS NEOPRENE. LINED GLOVES
REC FOR PROT FROM COLD.
Eye Protection:ANSI APPRVD CHEMICAL WORKERS GOGGLES .
Other Protective Equipment:EMERGENCY EYE WASH & DELUGE SHOWER MEETING
ANSI DERSIGN CRITERIA . WEAR APPROPRIATE CHEMICAL RESISTANT
PROTECTIVE CLOTHING TO PREVENT SKIN CONTACT.
Work Hygienic Practices:NONE SPECIFIED BY MANUFACTURER.
Supplemental Safety and Health
EFTS OF EXPOS: DENSE VAP OF CFC 115 DISPLACES AIR IN CONFINED PLACES &
REDUCES AVAIL OXYG FOR BRTHG. UPON EXPOS TO SUCH ATM, PERS MAY
EXPER SYMPS OF OXYG DEFICIENCY INCL HDCH, DIZZ, DROW, CYANOSIS & L
ACK OF MUSC CONTROL FOLLOWED BY COLLAPSE. PRLGD EXPOS TO
OXYG-DEFICIENT ATM MAY BE FATAL. AS W/MANY OTHER (OTHER INFO)
================== Physical/Chemical Properties ==================
HCC:G3
Boiling Pt:=-45.6C, -50.F
Vapor Pres:151.3 PSIA @ 70F
Vapor Density:3.8
Spec Gravity:1.22 (H*20 =1)
Solubility in Water:SLIGHT
Appearance and Odor:CLEAR, COLORLESS LIQUIFIED GAS WITH FAINT ETHEREAL
(ETHER-LIKE) ODOR.
Percent Volatiles by Volume:100
================= Stability and Reactivity Data =================
Stability Indicator/Materials to Avoid:YES
AVOID CONT W/STRONG ALKALI/ALKALINE EARTH METALS, FINELY POWDERED
METALS SUCH AS ALUMINUM, MAGNESIUM/ZINC & STRONG OXIDIZERS SINCE
THEY MAY REACT W/OR ACCELERATE DECOMPOSITION OF THIS MATERIAL.
Stability Condition to Avoid:THERMAL DECOMPOSITION DUE TO EXPOSURE TO
HEAT (>800F) OR FIRE.
Hazardous Decomposition Products:THERMAL DECOMPOSITION PRODUCTS INCLUDE
HYDROGEN FLUORIDE, HYDROGEN CHLORIDE, CARBON MONOXIDE, CARBON
DIOXIDE & CHLORINE. PHOGENE .
Conditions to Avoid Polymerization:FLAMES, EXTREMELY HOT METAL
SURFACES, HEATING ELEMENTS, COMBUSTION ENGINES, ETC.
=================== Toxicological Information ===================
Toxicological Information:TARGET ORGANS: EYES, SKIN, CNS, RESP SYS,
HEART. DATA FROM SCIENTIFIC LITERATURE ON CHLORODIFLUOROMETHANE ARE
SUMMARIZED: SINGLE EXPOS (ACUTE) STUDIES INDICATE: INHAL-PRACT
NON-TOXIC (2 HR-LD50 = 300, 000 (RAT), 390,000 PPM (MOUSE).
INHAL-RAT 10 MIN-EC50 = 140,000 (CNS EFTS) EYE IRRIT-SLIGHTLY IRRIT
TO RABBITS (5-30 SEC EXPOS TO GAS SPRAY). SKIN IRRIT-(MOD) IRRIT TO
RABBITS (LIQUEFIED GAS W/PATCH A PPLIED). THERE HAVE BEEN SEVERAL
ACCIDENTAL DEATHS ASSOC W/EXPOS TO CHLORODIFLUOROMETHANE/MIXTS
W/OTHER FLUOROCARBONS. DEATH WAS GEN ATTRIBUTED TO OXYG DEFICIENCY.
MICROSCOPIC EXAMINATION OF TISS OF S OME OF VICTIMS SHOWED (OTHER
INFO)
===================== Ecological Information =====================
Ecological:OTHER INFO: IN LIVER CELLS. AN INCR IN INCIDENCE OF HEART
PALPITATIONS HAVE BEEN CLAIMED BY INDIV OCCUP EXPOSED TO
CHLORODIFLUOROMETHANE. MONITORING OF WORKERS DURING OCCUP EXPOS TO
CHLORODIFLUOROMETH ANE SHOWED NO CONNECTION TO EXPOS & CARDIAC
ARRHYTHMIA OR NEUROLOGIC DISORDERS. OTHER EPIDEMIOLOGICAL STUDIES
HAVE RPTD SIMILAR RSLTS. RPTD DAILY APPLIC OF 10 SEC SPRAY CAUSED
REDDENING & SLIGHT SWELL OF SKIN & DELAY IN HAIR GROWTH. SKIN
ALLERGY WAS NOT OBSEVED IN GUINEA PIGS FOLLOWING RPTD SKIN EXPOS TO
CHLORODIFLUOROMETHANE. INHAL CAUSES INITIAL STIMULATION & THEN
DEPRESSION OF CNS. SYMPS IN ANI MALS INCL LOSS OF (TRANSPORT INFO)
==================== Disposal Considerations ====================
Waste Disposal Methods:RECYCLE/RECLAIM IF POSSIBLE. RECLAIMED MATERIAL
MAY BE INCINERATED BUT TOXIC & CORROSIVE COMBUSTION PRODUCTS (HF &
HCL) MUST BE HANDLED APPROPRIATELY. CONSULT FEDERAL, STATE, OR
LOCAL AUTHORITIES FOR PROPER DISPOSAL PROCEDURES.
=================== MSDS Transport Information ===================
Transport Information:ECOLOGICAL INFO: EQUILIBRIUM, TREMORS, CONVULS,
NARCOSIS & DEATH, USUALLY ATTRIBUTED TO ASPHY. AT LEVS OF
CHLORODIFLUOROMETHANE THAT CAUSED ANESTH, DOGS EXHIBITED CONVULS.
EXPOS BY INHAL AT 300,000 TO 400,000 PPM FOR 10-15 MINS WAS FATAL
TO RABBITS, ALSO CAUSING HEMORRHAGES & EFTS ON LIVER. FOLLOWING
INHAL EXPOS TO CHLORODIFLUOROMETHANE FOR 50,000 PPM FOR 1 MONTH, NO
EFTS WERE RPTD IN GUINEA PIGS ,RATS. DOGS & CATS; 60,000 PPM FOR
2-3 MONTHS ELICITED MILD LIVER EFTS IN RABBITS; 5,000 PPM FOR 3
MONTHS CAUSED NO NEUROTOXIC EFTS IN RATS; 14,000 PPM FOR 10 MONTHS
PRDCED EFTS ON LUNGS, CNS, HEART, LIVER, KIDNEY, SPLEEN OF(FED REG
INFO)
===================== Regulatory Information =====================
SARA Title III Information:HEALTH HAZARD CATEGORIES UNDER CRITERIA OF
SARA TITLE III RULES (40 CFR PART 370): IMMEDIATE. THIS CHEMICAL
(OR CHEMICALS) IS RPTD ON U.S. ENVIRONMENTAL PROT AGENCY TOXIC
SUBSTANCES CTL ACT INVENTORY. THIS PROD CNTNS SUBSTANCE(S) WHICH
AREDEFINED AS TOXIC CHEMS UNDER, & ARE SUBJECT TO RPTG REQUIREMENTS
OF, SECTION 313 OF TITLE III OF SUPERFUND AMENDMENTS &
REAUTHORIZATION ACT OF 1986 & SECTION OF THIS MSDS FOR CHEM
IDENTITIES & CONCS: CHEM FATE INFO: NO DATA AVAIL. HAZARD
CATEGORIES UNDER CRITERIA OF SARA TITLE III RULES (40 CFR PART
370): IMMEDIATE.
Federal Regulatory Information:TRANS INFO: RATS, MICE & RABBITS, WHILE
@ 2,000 PPM NO EFTS WERE RPTD IN RATS & MICE. AN INCR IN MALIGNANT
TUMORS OF SALIVARY GLANDS WAS RPTD IN MALE RATS BUT NOT IN FEMALE
RATS/MICE OF EITHER SEX AFT ER INHAL EXPOS TO 50,000 PPM 5 HR/DAY,
5DAY/WK FOR 21 MONTHS. LONG TERM INHAL OF 5,000 PPM WAS NOT CARCIN
TO RATS & MICE. ORAL DOSING FOR 52 WKS PRDCD NO ADVERSE EFTS IN
RATS. INHAL @ LEVS UP TO 50,00 0 7 100,.000 PPM PRDCD NO ADVERSE
EFTS ON MALE REPRO PERFORMANCE IN RATS & MICE. EYE MALFORMATIONS W
ER RPTD IN RATS EXPOS BY INHAL DURING PREGNANCY AT 50,000 PPM. IN
RATS @ 1000 PPM/IN RABBITS EXPOS @ LEVS UP TO 50,000 PPM. (ST REG
INFO)
State Regulatory Information:FED REG INFO: IN RABBITS, RATS 7 HUMANS,
SM PORTION OF INHALED CHLORODIFLUOROMETHANE WAS DISTRIBUTED INTO
BRAIN, HEART, LUNGS, LIVER, KIDNEYS & FAT. IT WAS RAPIDLY ELIM FROM
BODY IN INHALED AIR. NO SI GNIFICANT METABOLISM OCCURS IN
HUMANS/RATS. RSLTS OF TESTS FOR GENETIC CHGS WERE MIXED. STUDIES
W/MICE, DOGS, RATS, RABBITS, CATS & MONKEYS HAVE SHOWN THAT INHAL
EXPOS CAN CAUSE CARDIAC ARRHYS. NOEL F OR CARDIAC SENSIT IN DOGS IS
25,000 PPM. FORANE 115: SINGLE EXPOS (ACUTE) STUDIES INDICATE
INHAL-PRA CT NON-TOX TO RATS & GUINEA PIGS (4-HR LC50 >800,000
PPM). FOR MORE DETAILED INFO ON TOXICOLOGICAL INFO CONTACT NEHC .
======================= Other Information =======================
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
*** END OF RECORD *** |
|